Pharma Equity Group A/S (CPH:PEG)

Denmark flag Denmark · Delayed Price · Currency is DKK
0.100
-0.004 (-3.85%)
At close: Feb 27, 2026
-29.82%
Market Cap 122.76M
Revenue (ttm) n/a
Net Income (ttm) -21.02M
Shares Out 1.23B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 22,667
Average Volume 190,003
Open 0.102
Previous Close 0.104
Day's Range 0.091 - 0.102
52-Week Range 0.071 - 0.150
Beta 1.01
RSI 48.48
Earnings Date Mar 18, 2026

About Pharma Equity Group

Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement. Its products under development that are in Phase II clinical trials include RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of Ulcus Cruris chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouch... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Denmark
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol PEG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.